IGF2BP1 and breast carcinoma: Using the expression and clinical data from the TCGA-BRCA dataset, we demonstrated that the expression of IGF2BP1 mRNA was markedly correlated with histologic type (Figure 3A), and that molecular subtypes of breast cancer were defined by HER2 status (Figure 3B) or PAM50 (Figure 3C).